Chemistry Service Platform - CRO in Medicinal Chemistry

Axon Ligands (TM) - alphabetic: [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z]

 

 

 

  

NU 1025

 

CAS 90417-38-2

C9H8N2O2 

MW 176.17

Purity: >99%

 

 

 

 

Ordering Information:

 

Cat. No. Axon 1370     

 

Qty1: 10 mg /  €85  $111

 

Qty2: 50 mg / €315  $410

 

Qty3: on request

 

Send enquiry to: order@axonmedchem.com

or by fax to: +31-50-3600390.

 

Contact us for our product range and services.

Biological Activity:

 

Potent inhibitor of poly(ADP-ribose) polymerase (PARP); reported to have neuroprotective effects.

 

References: online 1, 2, 3

 

R Kaundal et al. Neuroprotective effects of NU1025, a PARP inhibitor in cerebral ischemia are mediated through reduction in NAD depletion and DNA fragmentation. Life Sciences 2006, 79(24), 2293-302.

 

KJ Bowman et al. Potentiation of anti-cancer agent cytotoxicity by the potent poly(ADP-ribose) polymerase inhibitors NU1025 and NU1064. Br. J. Cancer. 1998, 78 1269.

 

CA Delaney et al. Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell lines. Clin. Cancer Res. 2000, 6, 2860.

 

 

Chemical Name: 8-Hydroxy-2-methyl-3H-quinazolin-4-one

 

NU 1025 | PARP Inhibitor | Axon Medchem | Axon 1370 | NU1025

 

Axon Ligands TM - Research chemicals for biological study. Some high-profile samples could be provided under terms of contract research synthesis.

axonmedchem.com © 2011

 

Axon Ligands in the field:

 

ABT 888 | PARP inhibitor

AG 014699 | PARP inhibitor

DR 2313 | PARP inhibitor

Iniparib | PARP inhibitor

NU 1025 | PARP inhibitor

Olaparib | PARP inhibitor

 

 

Click Here To See Featured Cell Signaling and Oncology Ligands from Axon Ligands Collection